| Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis T McKerrell, N Park, T Moreno, CS Grove, H Ponstingl, J Stephens, ... Cell reports 10 (8), 1239-1245, 2015 | 528 | 2015 |
| Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis T McKerrell, N Park, T Moreno, CS Grove, H Ponstingl, J Stephens, ... Cell reports 10 (8), 1239-1245, 2015 | 525 | 2015 |
| Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice GS Vassiliou, JL Cooper, R Rad, J Li, S Rice, A Uren, L Rad, P Ellis, ... Nature genetics 43 (5), 470-475, 2011 | 260 | 2011 |
| Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? CS Grove, GS Vassiliou Disease models & mechanisms 7 (8), 941-951, 2014 | 248 | 2014 |
| A genetic progression model of BrafV600E-induced intestinal tumorigenesis reveals targets for therapeutic intervention R Rad, J Cadiñanos, L Rad, I Varela, A Strong, L Kriegl, ... Cancer cell 24 (1), 15-29, 2013 | 242 | 2013 |
| Vascular endothelial growth factor: the key mediator in pleural effusion formation CS Grove, YCG Lee Current opinion in pulmonary medicine 8 (4), 294-301, 2002 | 220 | 2002 |
| Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia MWM Kühn, E Song, Z Feng, A Sinha, CW Chen, AJ Deshpande, ... Cancer discovery 6 (10), 1166-1181, 2016 | 205 | 2016 |
| KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype A Clipson, M Wang, L De Leval, M Ashton-Key, A Wotherspoon, ... Leukemia 29 (5), 1177-1185, 2015 | 179 | 2015 |
| Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia MA Dawson, EJ Gudgin, SJ Horton, G Giotopoulos, E Meduri, S Robson, ... Leukemia 28 (2), 311-320, 2014 | 175 | 2014 |
| A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice A Mupo, L Celani, O Dovey, JL Cooper, C Grove, R Rad, P Sportoletti, ... Leukemia 27 (9), 1917-1920, 2013 | 101 | 2013 |
| A simple assay for a human serum phospholipase A2 that is associated with high-density lipoproteins N Petrovic, C Grove, PE Langton, NLA Misso, PJ Thompson Journal of lipid research 42 (10), 1706-1713, 2001 | 75 | 2001 |
| Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies T McKerrell, T Moreno, H Ponstingl, N Bolli, JML Dias, G Tischler, ... Blood, The Journal of the American Society of Hematology 128 (1), e1-e9, 2016 | 68 | 2016 |
| Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia OM Dovey, JL Cooper, A Mupo, CS Grove, C Lynn, N Conte, RM Andrews, ... Blood, The Journal of the American Society of Hematology 130 (17), 1911-1922, 2017 | 65 | 2017 |
| Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice MJ Friedrich, L Rad, IF Bronner, A Strong, W Wang, J Weber, M Mayho, ... Nature protocols 12 (2), 289-309, 2017 | 54 | 2017 |
| PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice J Weber, J de la Rosa, CS Grove, M Schick, L Rad, O Baranov, A Strong, ... Nature Communications 10 (1), 1415, 2019 | 50 | 2019 |
| Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol N Bolli, N Manes, T McKerrell, J Chi, N Park, G Gundem, MA Quail, ... Haematologica 100 (2), 214, 2015 | 48 | 2015 |
| Acute myeloid leukaemia in W estern A ustralia 1991–2005: a retrospective population‐based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome SA Gangatharan, CS Grove, S P'ng, J O'Reilly, D Joske, MF Leahy, ... Internal medicine journal 43 (8), 903-911, 2013 | 42 | 2013 |
| Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib SJ Taylor, JM Duyvestyn, SA Dagger, EJ Dishington, CA Rinaldi, ... Science translational medicine 9 (402), eaam8060, 2017 | 40 | 2017 |
| Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML S de Botton, P Fenaux, K Yee, C Récher, AH Wei, P Montesinos, ... Blood advances 7 (13), 3117-3127, 2023 | 35 | 2023 |
| Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture N Conte, I Varela, C Grove, N Manes, K Yusa, T Moreno, ... Leukemia 27 (9), 1820-1825, 2013 | 34 | 2013 |
